Codexis (CDXS) Free Cash Flow (2010 - 2026)
Codexis' (CDXS) quarterly Free Cash Flow came in at -$13.8 million in Q1 2026, up 8.63% year-on-year from -$12.7 million in Q1 2025, and down 186.87% quarter-over-quarter from $15.8 million in Q4 2025.
Codexis (CDXS) Free Cash Flow (2010 - 2026) Analysis & Trends
Codexis' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$13.8 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 8.63% year-over-year to -$13.8 million in Q1 2026; TTM through Mar 2026 was -$22.5 million, a 62.33% increase from a year earlier, with the FY2025 full-year figure at -$23.8 million, up 55.6% from the prior year.
- Free Cash Flow slipped to -$13.8 million in Q1 2026 per CDXS's latest filing, from $15.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $18.4 million in Q3 2022 and bottomed at -$20.5 million in Q4 2024.
- The 5-year median for Free Cash Flow is -$12.3 million (2023), against an average of -$8.1 million.
- Across the five-year window, Free Cash Flow surged 356.43% in 2022 and tumbled 328.63% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at $12.4 million in 2022, then tumbled by 223.75% to -$15.3 million in 2023, then tumbled by 34.18% to -$20.5 million in 2024, then surged by 177.14% to $15.8 million in 2025, then plunged by 186.87% to -$13.8 million in 2026.
- Per Business Quant, the three latest CDXS Free Cash Flow figures stand at -$13.8 million (Q1 2026), $15.8 million (Q4 2025), and -$7.9 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | -13.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.75 Mn |
| Mar 31, 2026 | -13.75 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Sep 30, 2025 | -7.87 Mn |
| Sep 30, 2025 | -7.87 Mn |
| Jun 30, 2025 | -16.76 Mn |
| Jun 30, 2025 | -16.76 Mn |
| Mar 31, 2025 | -15.05 Mn |
| Mar 31, 2025 | -15.05 Mn |
| Dec 31, 2024 | -20.52 Mn |
| Dec 31, 2024 | -20.52 Mn |
| Sep 30, 2024 | -11.71 Mn |
| Sep 30, 2024 | -11.71 Mn |
| Jun 30, 2024 | -12.56 Mn |
| Jun 30, 2024 | -12.56 Mn |
| Mar 31, 2024 | -8.92 Mn |
| Mar 31, 2024 | -8.92 Mn |
| Dec 31, 2023 | -15.30 Mn |
| Dec 31, 2023 | -15.30 Mn |